Jubilant Innovation USA to receive up to $22.6 m over acquisition of drug development firm
The payments are on account of an acquisition by a large pharma company of one of their investee companies having assets in early…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 324
Browsing Category
Latest Updates
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
Zydus acquires gastro therapy ‘Actibile’ from Albert David
Strengthens its presence in the gastroenterology segment
Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has…
Panacea Biotec launches CABAPAN
CABAPAN is a cost effective product for the treatment of metastatic castration resistant prostrate cancer
Biocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17
DRL in agreement with XenoPort
DRL will be granted exclusive US rights for the development and commercialisation of XenoPort’s clinical-stage oral new chemical…
Glenmark receives US FDA approval for bendamustine hydrochloride injection
It is Glenmark’s first injectable approval in the US
Cadila Pharma initiates awareness campaigns to observe ‘World TB Day’
Multi-city patient awareness programmes, free diagnosis, rallies, radio, street play and film activity has been planned to raise…
MSF welcomes Ministry of Commerce clarification on Compulsory Licensing
Warns US pressure on India will continue
The Ministry of Commerce recently clarified that media reports claiming that the…